These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3334614)

  • 1. Comparative study of Ro 17-2301 (AMA-1080) and amikacin in complicated urinary tract infections.
    Hahn LB; Iribarren M; Barclay C; Casellas J; Traballi C; Farinati A
    Chemioterapia; 1987 Jun; 6(2 Suppl):519-21. PubMed ID: 3334614
    [No Abstract]   [Full Text] [Related]  

  • 2. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
    Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
    Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
    [No Abstract]   [Full Text] [Related]  

  • 3. Carumonam in the treatment of severe and complicated urinary tract infections.
    Kotilainen P; Huovinen P; Hänninen P
    Chemioterapia; 1987 Jun; 6(2 Suppl):514-5. PubMed ID: 3509487
    [No Abstract]   [Full Text] [Related]  

  • 4. Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.
    Westenfelder M; Frankenschmidt A; Pelz K
    Chemioterapia; 1987 Jun; 6(2 Suppl):515-6. PubMed ID: 3334612
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isepamicin versus amikacin in the treatment of urinary tract infection.
    Sturm W
    J Chemother; 1995 Jun; 7 Suppl 2():149-54. PubMed ID: 8622104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections.
    Melekos MD; Skoutelis A; Chryssanthopoulos C; Bassaris HP
    J Chemother; 1991 Dec; 3(6):376-82. PubMed ID: 1819621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of aztreonam and cefamandole in the treatment of serious urinary tract infections.
    Tsouroutsoglou W; Sion ML; Stathopoulos GA; Kapoulas S; El-Messidi M; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):385-90. PubMed ID: 6684719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily isepamicin treatment in complicated urinary tract infections.
    Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
    J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin--single dose treatment for uncomplicated urinary tract infections in children.
    Krzeska I
    J Chemother; 1989 Jul; 1(4 Suppl):862-3. PubMed ID: 16312674
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative multicenter study between aztreonam and gentamycin in the treatment of renal and urinary infections].
    Albertazzi A; Bonadio M; Fusaroli M; Miano L; Lotti T; Salvia G; Sasdelli M; Villa G; Zucchelli P
    G Ital Chemioter; 1985; 32(2):465-8. PubMed ID: 3914436
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of the effectiveness and renal tolerance of aztreonam (1 daily dosage) and gentamycin (2 daily doses) in the therapy of renal and urinary infections].
    Bonadio M; Maccanti O; Pulitanò L; Galigani P; Palla R
    G Ital Chemioter; 1985; 32(2):459-63. PubMed ID: 3914435
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of azthreonam in severe urinary tract infections].
    Guibert J; Acar JF; Miegi M
    Pathol Biol (Paris); 1984 May; 32(5):446-9. PubMed ID: 6377208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of the therapeutic effect of vistamycin and kanamycin on the various urinary tract infections--analysis by double blind method].
    Shishito S
    Hinyokika Kiyo; 1972 Mar; 18(3):160-72. PubMed ID: 4558366
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview of the efficacy of isepamicin in the adult core clinical trial programme.
    Carbon C
    J Chemother; 1995 Jun; 7 Suppl 2():79-85. PubMed ID: 8622115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the local use of amikacin].
    Wada S; Nishio S; Kishimoto T; Maekawa M; Yuki K; Sasaki S; Oshima N; Hayahara N; Nishijima T; Funai K
    Hinyokika Kiyo; 1985 May; 31(5):907-13. PubMed ID: 4050636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.